Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.
Deacon
Carolyn F
CF
Department of Medical Physiology, The Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark. deacon@mfi.ku.dk
Holst
Jens J
JJ
D003924:Diabetes Mellitus, Type 2 / Q000201:enzymology / Q000266:history* / Q000517:prevention & control; D018819:Dipeptidyl Peptidase 4 / Q000266:history*; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D049673:History, 20th Century; D049674:History, 21st Century; D010446:Peptide Fragments / Q000378:metabolism; D011480:Protease Inhibitors / Q000266:history* / Q000627:therapeutic use; D011498:Protein Precursors / Q000378:metabolism
D010446:Peptide Fragments; D011480:Protease Inhibitors; D011498:Protein Precursors; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D018819:Dipeptidyl Peptidase 4